Pedro Cuatrecasas is known for the invention and development of affinity chromatography, a process utilized within the Aethlon HemopurifierTM. He was involved in the discovery, development and marketing registration of more than forty medicines. Some of those medicines include: zidovudine (AZT, AIDS), acyclovir (Zovirax, anti-herpes), permethrin (Rid, head and body lice), bupropion (Wellbutrin, antidepressant), colfosceril palmitate (Exosurf, infant acute respiratory distress), remifentanil (Ultiva, analgesic/anesthetic), sumatriptan (Imigran, migraine), salmeterol (Serement, asthma), tacrine (Cognex, Alzheimers), gabapentin (Neurontin, epilepsy and neuropathic pain), troglitazone (Rezulin, diabetes), and atorvastatin (Lipitor, cholesterol lowering).
Wikimedia Commons has media related to Pedro Cuatrecasas.
Researchers Share Prize in Medicine
April 11, 2024
pedro, cuatrecasas, this, biography, living, person, needs, additional, citations, verification, please, help, adding, reliable, sources, contentious, material, about, living, persons, that, unsourced, poorly, sourced, must, removed, immediately, from, article. This biography of a living person needs additional citations for verification Please help by adding reliable sources Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page especially if potentially libelous Find sources Pedro Cuatrecasas news newspapers books scholar JSTOR February 2013 Learn how and when to remove this template message Pedro Cuatrecasas born 27 September 1936 is an American biochemist and an Adjunct Professor of Pharmacology amp Medicine at the University of California San Diego 1 Pedro CuatrecasasBorn 1936 09 27 27 September 1936 age 87 Madrid SpainCitizenshipAmericanEducationWashington University School of Medicine M D 1962Known forInvention of affinity chromatographyAwardsWolf Prize in MedicineScientific careerFieldsBiochemistry pharmacology medicineInstitutionsUC San Diego Contents 1 Birth and education 2 Research 3 References 4 External linksBirth and education editPedro Cuatrecasas was born in 1936 in Madrid Spain 2 He completed his A B from Washington University in St Louis in 1958 He completed his M D from Washington University School of Medicine in 1962 Research editPedro Cuatrecasas is known for the invention and development of affinity chromatography a process utilized within the Aethlon HemopurifierTM He was involved in the discovery development and marketing registration of more than forty medicines Some of those medicines include zidovudine AZT AIDS acyclovir Zovirax anti herpes permethrin Rid head and body lice bupropion Wellbutrin antidepressant colfosceril palmitate Exosurf infant acute respiratory distress remifentanil Ultiva analgesic anesthetic sumatriptan Imigran migraine salmeterol Serement asthma tacrine Cognex Alzheimers gabapentin Neurontin epilepsy and neuropathic pain troglitazone Rezulin diabetes and atorvastatin Lipitor cholesterol lowering In 1987 Pedro Cuatrecasas won the Wolf Prize in Medicine in 1987 along with Meir Wilchek for the invention and development of affinity chromatography and its applications to biomedical sciences 3 References edit Pedro Cuatrecasas at the University of California San Diego Archived from the original on 2008 05 16 Retrieved 2007 09 23 The International Who s Who 1989 90 Europa Publications 1989 ISBN 9780946653508 The Wolf Prize in MedicineExternal links edit nbsp Wikimedia Commons has media related to Pedro Cuatrecasas CV of Pedro Cuatrecasas Researchers Share Prize in Medicine The Wolf Prize in Medicine in 1987 detail Retrieved from https en wikipedia org w index php title Pedro Cuatrecasas amp oldid 1197728272, wikipedia, wiki, book, books, library,
